Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study
Objective We sought to verify if an oral contraceptive (OC) containing drospirenone affects the cardiovascular risk of patients with polycystic ovary syndrome (PCOS). Study Design A total of 28 women…